Skip to main content
. 2014 Oct 11;6(5):604–613.

Table 2.

Correlation between the expression of miRNA-21 and miRNA-375 and clinicopathological factors in laryngeal SCC patients

Relative expression of miR-21 Relative expression of miR-375

n High Low P-value High Low P-value
Total 46 24 (52.2%) 22 (47.8%) 23 (50.0%) 23 (50.0%)
Gender
    Male 42 22 (52.4%) 20 (47.6%) 20 (47.6%) 22 (52.4%)
    Female 4 2 (50.0%) 2 (50.0%) 1.000 3 (75.0%) 1 (25.0%) 0.608
Age (y)
    < 65 22 12(54.5%) 10 (45.5%) 12 (54.5%) 10 (45.5%)
    ≤ 65 24 12(50.0%) 12 (50.0%) 0.990 11 (45.8%) 13 (54.2%) 0.768
T stage
    T0/1/2 21 12 (57.1%) 9 (42.9%) 13 (61.9%) 8 (38.1%)
    T3/4 25 12 (48.0%) 13 (52.0%) 0.747 10 (40.0%) 15 (60.0%) 0.236
N stage
    Negative 32 17 (53.1%) 15 (46.9%) 18 (56.3%) 14 (43.8%)
    Positive 14 7 (50.0%) 7 (50.0%) 1.000 5 (35.7%) 9 (64.3%) 0.336
Stage
    Low (I-II) 31 13 (41.9%) 18 (58.1%) 19 (61.3%) 12 (38.7%)
    High (III-IV) 15 11 (73.3%) 4 (26.7%) 0.092 4 (26.7%) 11 (73.3%) 0.059
Localization
    Glottic 33 18 (54.5%) 15 (45.5%) 20 (60.6%) 13 (39.4%)
    Supraglottic 11 5 (45.5%) 6 (54.5%) 0.862 2 (18.2%) 9 (81.8%) 0.037
    Subglottic 2 1 (50.0%) 1 (50.0%) 1 (50.0%) 1 (50.0%)
Smokinga
    Negative 12 5 (41.7%) 7 (58.3%) 6 (50.0%) 6 (50.0%)
    Positive 31 18 (58.1%) 13 (41.9%) 0.531 15 (48.4%) 16 (51.6%) 1.000
Alcoholb
    Negative 22 11 (50.0%) 11 (50.0%) 15 (68.2%) 7 (31.8%)
    Positive 19 10 (52.6%) 9 (47.4%) 1.000 6 (31.6%) 13 (68.4%) 0.043
a

Data missing in 3 samples;

b

Data missing in 5 samples; p < 0.05.

Note: Correlation between the expression of miRNA-21 and miRNA-375 and clinicopathological factors in laryngeal SCC patients. p values, as calculated using the χ2 or Fisher’s exact test, are shown, with p < 0.05 considered statistically significant.